Announcements Trials

Browse Landscape

Phase

Phase 2 3 Phase EARLY_PHASE1 1 Phase 4 1 Phase 1/2 1

Status

Withdrawn 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 15 Neoplasms 11 Pancreatic Neoplasms 10 Prostatic Neoplasms 7 Glioma 6 Squamous Cell Carcinoma of Head and Neck 5 Ovarian Neoplasms 5 Head and Neck Neoplasms 5 Glioblastoma 5 Carcinoma, Non-Small-Cell Lung 5 Triple Negative Breast Neoplasms 4 Sarcoma 4 Polycystic Ovary Syndrome 4 Colonic Neoplasms 4 Obesity 3 Neoplasm Metastasis 3 Multiple Myeloma 3 Melanoma 3 Lung Neoplasms 3 Carcinoma, Intraductal, Noninfiltrating 3 Brain Neoplasms 3 Pain, Postoperative 2 Lymphoma 2 Fallopian Tube Neoplasms 2 Esophageal Neoplasms 2 Endometrial Neoplasms 2 Depression 2 Cholangiocarcinoma 2 Central Nervous System Neoplasms 2 Carcinoma, Renal Cell 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Withdrawn × Stomatitis × Clear all

NCT05104268 2024-02-20

MDOM

E2Bio Life Sciences, LLC

Phase EARLY_PHASE1 Withdrawn

Neoplasms, Stomatitis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡